New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk

(Press-News.org) Guideline Highlights:

Nearly half of all adults in the U.S. have high blood pressure (≥130/80 mm Hg), which is the #1 preventable risk factor for cardiovascular disease, including heart attack, stroke and heart failure, as well as kidney disease, cognitive decline and dementia. A new joint guideline from the American Heart Association and the American College of Cardiology advises earlier treatment that includes lifestyle modification and medications as appropriate, recommends close blood pressure management before, during and after pregnancy, and highlights using the new PREVENT™ risk calculator to estimate a person’s cardiovascular disease risk to tailor treatment. The new guideline also reinforces the importance of healthy lifestyle behaviors, such as eating a nutritious diet, being physically active, and maintaining or achieving a healthy weight. More recent research confirms that blood pressure affects brain health, including cognitive function and dementia, so early treatment is recommended for people diagnosed with high blood pressure to maintain brain health and cognition. High blood pressure before, during and after pregnancy is important to monitor and treat quickly to reduce the risk of short- and long-term serious complications including preeclampsia. The guideline, led by the American Heart Association and American College of Cardiology Joint Committee on Clinical Practice Guidelines, was developed in collaboration with and endorsed by 11 other health care organizations: the American Academy of Physician Associates; the American Association of Nurse Practitioners; the American College of Clinical Pharmacy; the American College of Preventive Medicine; the American Geriatrics Society; the American Medical Association; the American Society of Preventive Cardiology; the Association of Black Cardiologists; the National Medical Association; the Preventive Cardiovascular Nurses Association; and the Society of General Internal Medicine. Embargoed until 1:00 p.m. CT/2:00 p.m. ET Thursday, August 14, 2025

DALLAS and WASHINGTON, August 14, 2025 — Preventing and managing high blood pressure with healthy lifestyle behaviors, such as following a heart-healthy diet including reducing salt intake, staying physically active, maintaining a healthy weight and managing stress—combined with early treatment with medication to lower blood pressure if necessary—are recommended to reduce the risk of heart attack, stroke, heart failure, kidney disease, cognitive decline and dementia, according to a new clinical guideline published today in the American Heart Association’s peer-reviewed journals Circulation and Hypertension, and in JACC, the flagship journal of the American College of Cardiology.

The “2025 AHA / ACC / AANP / AAPA / ABC / ACCP / ACPM / AGS / AMA / ASPC / NMA / PCNA / SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” replaces the 2017 guideline and includes new or updated recommendations for blood pressure management based on the latest scientific evidence to achieve the best health outcomes for patients.

The new guideline reflects several major changes since 2017, including use of the American Heart Association’s PREVENTTM (Predicting Risk of cardiovascular disease EVENTs) risk calculator to estimate cardiovascular disease risk. It also provides updated guidance on medication options, including the early treatment for high blood pressure to reduce the risk of cognitive decline and dementia; use of specific medications including the possible addition of newer therapies such as GLP-1 medications for some patients with high blood pressure and overweight or obesity, and recommendations for managing high blood pressure before, during and after pregnancy.

High blood pressure (including stage 1 or stage 2 hypertension) affects nearly half (46.7%) of all adults in the U.S., is the leading cause of death in the U.S. and around the world. The blood pressure criteria remain the same as the 2017 guideline:

normal blood pressure is less than 120/80 mm Hg; elevated blood pressure is 120-129/80 mm Hg; stage 1 hypertension is 130-139 mm Hg or 80-89 mm Hg; and stage 2 hypertension is ≥140 mm Hg or ≥90 mm Hg.  “High blood pressure is the most common and most modifiable risk factor for heart disease,” said Chair of the guideline writing committee Daniel W. Jones, M.D., FAHA, dean and professor emeritus of the University of Mississippi School of Medicine in Jackson, Mississippi, and was a member of the writing committee for the 2017 high blood pressure guideline. “By addressing individual risks earlier and offering more tailored strategies across the lifespan, the 2025 guideline aims to aid clinicians in helping more people manage their blood pressure and reduce the toll of heart disease, kidney disease, Type 2 diabetes and dementia.”

“This updated guideline is designed to support health care professionals—from primary care teams to specialists, and to all clinicians across health systems—with the diagnosis and care of people with high blood pressure. It also empowers patients with practical tools that can support their individual health needs as they manage their blood pressure, whether through lifestyle changes, medications or both,” Jones said.

Importance of healthy lifestyle

The new guideline reaffirms the critical role healthy lifestyle behaviors play in preventing and managing high blood pressure, and it encourages health care professionals to work with patients to set realistic, achievable goals. Healthy behaviors such as those in Life’s Essential 8, the American Heart Association’s metrics for heart health, remain the first line of care for all adults.

Specific blood pressure-related guidance includes:

limiting sodium intake to less than 2,300 mg per day, moving toward an ideal limit of 1,500 mg per day by checking food labels (most adults in the U.S. get their sodium from eating packaged and restaurant foods, not the salt shaker); ideally, consuming no alcohol or for those who choose to drink, consuming no more than two drinks per day for men and no more than one drink per day for women; managing stress with exercise, as well as incorporating stress-reduction techniques like meditation, breathing control or yoga; maintaining or achieving a healthy weight, with a goal of at least a 5% reduction in body weight in adults who have overweight or obesity; following a heart healthy eating pattern, for example the DASH eating plan, which emphasizes reduced sodium intake and a diet high in vegetables, fruits, whole grains, legumes, nuts and seeds, and low-fat or nonfat dairy, and includes lean meats and poultry, fish and non-tropical oils; increasing physical activity to at least 75-150 minutes each week including aerobic exercise (such as cardio) and/or resistance training (such as weight training); and home blood pressure monitoring is recommended for patients to help confirm office diagnosis of high blood pressure and to monitor, track progress and tailor care as part of an integrated care plan.   Addressing each of these lifestyle factors is especially important for people with high blood pressure and other major risk factors for cardiovascular disease because it may prevent, delay or treat elevated or high blood pressure.

New risk calculator and earlier intervention

The new guideline recommends that health care professionals use the PREVENTTM risk calculator to estimate a person’s risk of a heart attack, stroke or heart failure. Developed by the American Heart Association in 2023, PREVENTTM is a tool to estimate 10- and 30-year risk of cardiovascular disease in people ages 30-79 years. It includes variables such as age, sex, blood pressure, cholesterol levels and other health indicators, including zip code as a proxy for social drivers of health. It is the first risk calculator that combines measures of cardiovascular, kidney and metabolic health to estimate risk for cardiovascular disease. More precise risk estimates can help guide treatment decisions personalized for each individual.

In addition to the use of the PREVENTTM risk assessment tool, the new guideline recommends two important changes to laboratory testing for initial evaluation.

The ratio of urine albumin and creatinine (a test that assesses kidney health) is now recommended for all patients with high blood pressure. It was recommended as an optional test in the 2017 guideline. The guideline also expands the indication for use of the plasma aldosterone-to-renin ratio test as a screening tool for primary aldosteronism in more patients including those with obstructive sleep apnea. (Primary aldosteronism is a condition that occurs when the adrenal glands make too much aldosterone, leading to high blood pressure and low potassium levels.) Screening for primary aldosteronism may also be considered in adults with stage 2 hypertension to increase rates of detection, diagnosis and targeted treatment. Association of high blood pressure with cognitive decline and dementia

While high blood pressure is a leading cause of heart attack and stroke, the new guideline highlights other serious risks. More recent research confirms that blood pressure affects brain health, including cognitive function and dementia. High blood pressure can damage small blood vessels in the brain, which is linked to memory problems and long-term cognitive decline. The guideline recommends early treatment for people diagnosed with high blood pressure with a goal of systolic blood pressure (top number) goal of <130 mm Hg for adults with high blood pressure to prevent cognitive impairment and dementia.

Tailored approaches to medication for high blood pressure

For many people with high blood pressure, especially those who have Type 2 diabetes, obesity or kidney disease, more than one medication may be needed to lower blood pressure to meet the <130/80 mm Hg criteria. The guideline highlights several types of blood pressure medications to initiate treatment, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), long-acting dihydropyridine calcium channel blockers and thiazide-type diuretics. If blood pressure remains high after one medication, clinicians may individualize treatment to either increase the dose or add a second medication from a different medication class.

The guideline maintains the recommendation to begin treatment with two medications at once – preferably in a single combination pill - for people with blood pressure levels 140/90 mm Hg or higher (stage 2 hypertension). The guideline also suggests possible addition of newer therapies such as GLP-1 medications for some patients with high blood pressure and overweight or obesity.

High blood pressure and pregnancy

High blood pressure during pregnancy can have lasting effects on the mother’s health, including an increased risk of future high blood pressure and cardiovascular conditions. Without treatment, high blood pressure during pregnancy can lead to serious complications, such as preeclampsia, eclampsia, stroke, kidney problems and/or premature delivery. Women with high blood pressure who are planning a pregnancy or are pregnant should be counseled about the potential benefits of low-dose aspirin (81 mg/day) to reduce the risk of preeclampsia.

For pregnant women with chronic hypertension (high blood pressure before pregnancy or diagnosed before 20 weeks of pregnancy), the new guideline recommends treatment with certain medications when systolic blood pressure reaches 140 mm Hg or higher and/or diastolic blood pressure reaches 90 mm Hg or higher. This change reflects growing evidence that tighter blood pressure control for some individuals during pregnancy may help to reduce the risk of serious complications.

In addition, postpartum care is especially important because high blood pressure can begin or persist after delivery. The guideline urges continued blood pressure monitoring and timely treatment during the postpartum period to help prevent complications. Patients with a history of pregnancy-associated high blood pressure are encouraged to have their blood pressure measured at least annually.

“It is important for people to be aware of the recommended blood pressure goals and understand how healthy lifestyle behaviors and appropriate medication use can help them achieve and maintain optimal blood pressure. Prevention, early detection and management of high blood pressure are critical to long-term heart and brain health, which means longer, healthier lives,” said Jones.

This guideline was prepared by a volunteer writing committee on behalf of the American Heart Association and the American College of Cardiology Joint Committee on Clinical Practice Guidelines, and in collaboration with and endorsed by the American Academy of Physician Associates, the American Association of Nurse Practitioners, the American College of Clinical Pharmacy, the American College of Preventive Medicine, the American Geriatrics Society, the American Medical Association, the American Society of Preventive Cardiology, the Association of Black Cardiologists, the National Medical Association, the Preventive Cardiovascular Nurses Association and the Society of General Internal Medicine.

Co-authors and members of the guideline writing committee include Co-Vice Chairs Keith C. Ferdinand, M.D., FAHA, FACC, and Sandra J. Taler, M.D., FAHA; Heather M. Johnson, M.D., M.S., FAHA, FACC; Daichi Shimbo, M.D.; Marwah Abdalla, M.D., M.P.H., FAHA, FACC; M. Martine Altieri, P.A.-C., M.H.Sc.; Nisha Bansal, M.D., M.A.S., FAHA; Natalie A. Bello, M.D., M.P.H., FACC; Adam P. Bress, Pharm.D., M.S.; Jocelyn Carter, M.D., M.P.H.; Jordana B. Cohen, M.D., M.S.C.E., FAHA; Karen J. Collins, M.B.A.; Yvonne Commodore-Mensah, Ph.D., M.H.S., B.S.N., R.N., FAHA; Leslie L. Davis, Ph.D., A.N.P.-B.C., FAHA, FACC; Brent Egan, M.D., FAHA; Sadiya S. Khan, M.D., M.Sc., FAHA, FACC; Donald M. Lloyd-Jones, M.D., Sc.M., FAHA, FACC; Bernadette Mazurek Melnyk, Ph.D., A.P.R.N.-C.N.P.; Eva A. Mistry, M.B.B.S., M.S.C.I., FAHA; Modele O. Ogunniyi, M.D., M.P.H., FAHA, FACC; Stacey L. Schott, M.D., M.P.H.; Sidney C. Smith Jr., M.D., FAHA; Amy W. Talbot, M.P.H.; Wanpen Vongpatanasin, M.D., FAHA, FACC; Karol E. Watson, M.D., Ph.D., FAHA, FACC; Paul K. Whelton, M.B., M.D., M.Sc., FAHA; and Jeff D. Williamson, M.D., M.H.S.

The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

Available multimedia is on right column of release link. News release translations in Spanish,Traditional Chinese (doc) and Chinese Simplified (doc) and Tagalog (doc) to be added as available.  After August 14, 2025, view the manuscript online in Circulation, Hypertension and JACC. American Heart Association health information: High Blood Pressure American Heart Association Guideline Hub for Health Care Professionals (at embargo lift – Thursday, Aug. 14, at 2 p.m. ET) 2025 High Blood Pressure Guideline Journal Hub (at embargo lift – Thursday, Aug. 14, at 2 p.m. ET) JACC.org Guideline Hub (at embargo lift – Thursday, Aug. 14, at 2 p.m. ET) 2025 High Blood Pressure Guideline-at-a-Glance (Available Aug. 15, at 2 p.m. ET) CardioSmart.org High Blood Pressure Hub Follow AHA/ASA news on X @HeartNews Follow the ACC at @ACCinTouch Follow news from the AHA’s flagship journal Circulation @CircAHA Follow news from the AHA’s Hypertension journal @HyperAHA Follow news from the ACC’s flagship journal JACC @JACCJournals ###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

About the American College of Cardiology
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

END